Table 1.

Cohort Clinical Data

	Maternal		Infant				GDM diagnostic criteria		Treatment
Study group	Age (years)	BMI (kg/m2)	Sex	Race/ethnicity	Birth weight (g)	Gestational age (weeks)	GCT	GTT	None/diet/oral/insulin
Control
Control 1	33	22.7	F	African American	3,375	39	Negative	n/a	None
Control 2	31	24.3	F	Hispanic	3,820	39	Negative	n/a	None
Control 3	37	30.0	F	Hispanic	3,560	40.2	n/a	Normal	None
Control 4	24	27.7	M	Hispanic	3,395	38.5	Positive	Normal	None
Control 5	20	23.4	M	African American	3,005	38	n/a	n/a	None
Control 6	27	29.4	F	Hispanic	3,180	40.5	Negative	n/a	None
Mean	28.7 ± 6.2	26.3 ± 3.2			3,389 ± 285	39.0 ± 1.0
LGA-GDM
LGA-GDM 1	36	37.5	M	Asian	4,265	38.6	Positive	n/a	Insulin
LGA-GDM 2	28	40.2	M	Hispanic	4,495	39.5	Positive	Abnormal	Diet
LGA-GDM 3	32	44.8	M	Hispanic	3,965	39.4	n/a	Abnormal	Diet
LGA-GDM 4	21	35.7	M	Asian	4,320	40.3	Positive	Abnormal	Diet
LGA-GDM 5	41	38.5	F	Hispanic	3,800	39.2	n/a	Abnormal	Oral
LGA-GDM 6	36	34.0	F	Hispanic	4,505	40.6	Negative	Abnormal	Diet
Mean	32.3 ± 7.1	38.4 ± 3.8a			4,225 ± 286a	39.6 ± 0.7

Clinical data of Control and LGA-GDM cohorts. Mean age, weight, BMI, birth weight, and gestational age, represented as mean ± standard deviation.

^aP value <0.05 measured by student's t-test.

BMI, body mass index; GCT, glucose challenge test; GDM, gestational diabetes mellitus; GTT, glucose tolerance test.